Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005915 · ClinicalTrials.gov registry record

A Comparison of Two Anti-HIV Treatment Plans

A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
480
Enrollment target
20
Study locations

NCT00005915 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 480 participants, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005915, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
480 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to compare 2 treatment plans to try to increase the effects of anti-HIV drugs in patients who are resistant to the drug effects. Sometimes the increase in a patient's viral load (the level of HIV in the blood) can be slowed or stopped by taking anti-HIV drugs. This does not always happen. Sometimes anti-HIV drugs work at first but then stop working. When most of the usual anti-HIV drugs no longer seem to work, the virus is called multidrug-resistant (MDR). This study will compare 2 treatment plans to try to increase the effects of anti-HIV drugs in patients with MDR virus.

Conditions Studied

HIV Infections

Study Locations (20)

Texas

  • Montrose Clinic - Houston
  • Houston Veterans Administration Med Ctr - Houston
  • Univ TX Health Science Ctr - Houston

California

  • Community Consortium / UCSF - San Francisco
  • Lawrence Goldyn, MD - San Francisco

Colorado

  • Denver CPCRA / Denver Public Hlth - Denver
  • Univ Hosp Infectious Disease - Denver

Louisiana

  • Louisiana Comm AIDS Rsch Prog / Tulane Univ Med - New Orleans
  • Our Lady of the Lake Regional Med Ctr - New Orleans

Michigan

  • Wayne State Univ - WSU/DMC / Univ Hlth Ctr - Detroit
  • Henry Ford Hosp - Detroit

New Jersey

  • Southern New Jersey AIDS Clinical Trials - Camden
  • North Jersey Community Research Initiative - Newark

New York

  • Harlem AIDS Treatment Grp / Harlem Hosp Ctr - New York
  • Bronx-Lebanon Hosp Ctr - The Bronx

Connecticut

  • Yale U / New Haven Med Ctr / AIDS Clinical Trials Unit - New Haven

Trial Details

FieldValue
Enrollment Target 480 participants
Est. Completion 2004-06

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00005915

The ClinicalTrials.gov registry entry for NCT00005915 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00005915 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Texas, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT00005915 about?

NCT00005915 is a clinical study titled "A Comparison of Two Anti-HIV Treatment Plans". The purpose of this study is to compare 2 treatment plans to try to increase the effects of anti-HIV drugs in patients who are resistant to the drug effects. Sometimes the increase in a patient's viral load (the level of HIV in the blood) can be slowed or stopped by taking anti-HIV drugs. This does...

What is the current status of trial NCT00005915?

This trial is currently completed. The enrollment target is 480 participants. Estimated completion is 2004-06.

What conditions does trial NCT00005915 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00005915?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005915 being conducted?

This trial has 20 study locations across California, Colorado, Connecticut, District of Columbia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.